Efavirenz (EFV)

Strength: 600 mg

Dosage Form: Tablet

Description:

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that suppresses HIV replication by inhibiting reverse transcriptase.

Key Features:

• Once-daily dosing, usually at bedtime
• Effective component of first-line ART regimens
• Crosses blood-brain barrier for CNS penetration

Precautions:

• May cause dizziness, vivid dreams, or mood changes
• Avoid use in pregnancy unless no alternatives
• Monitor for neuropsychiatric symptoms